Healthcare procurement is moving from back-office function to strategic cost control
Hospitals and health systems are under relentless pressure to reduce costs without weakening operations, and procurement has become one of the few places where that tension can be addressed directly. In a recent Healthcare Insider conversation, Tom Swapp, senior vice president of indirect spend and purchased services at Vizient, focused on the spending categories that often escape close scrutiny: indirect spend, purchased services, and capital expenditures. These are not minor line items. In many systems, they represent a large and structurally difficult share of the budget, especially when contracts are fragmented, buying decisions are decentralized, and spending data are hard to reconcile across sites.
The central message is blunt: significant value still sits outside managed procurement structures. Spend that remains unmanaged or off contract tends to erode margins quietly, because the leakage is spread across thousands of purchases rather than concentrated in one obvious failure. In a hospital setting, that can mean paying different prices for similar services, duplicating vendor relationships, or buying items that should have been routed through existing contracts. The operational consequence is not abstract. Every dollar lost through weak sourcing is a dollar that cannot be used for staffing, equipment replacement, patient services, or infrastructure upkeep.
Healthcare procurement has always been more complex than simple volume purchasing. Clinical necessity, supply chain resilience, regulatory scrutiny, and local preferences all shape buying behavior. But the sector is now facing a different kind of challenge: organizations are being asked to identify savings in areas that were historically treated as too diffuse or too specialized to optimize. Purchased services often fall into that category, along with indirect categories such as facilities support, information technology, consulting, and other nonclinical services that still carry real financial weight. When those categories are not systematically reviewed, health systems often have little visibility into where money is being lost.
Swapp’s discussion places procurement optimization in a more analytical frame. Instead of treating sourcing as a transactional task, the emphasis shifts to identifying patterns, prioritizing the highest-yield opportunities, and acting quickly enough to matter. The appeal of that model is easy to understand. Procurement teams rarely have unlimited time, and most systems cannot chase every contract at once. A structured approach helps separate routine purchasing from the areas where contract compliance, price discipline, and vendor consolidation can produce meaningful savings. In practical terms, the process depends on better data, sharper prioritization, and a willingness to revisit old buying habits.
One sentence captures the pressure point: unmanaged spend is often invisible until margins are already damaged.
Vizient’s new Agentic Sourcing enters at exactly that point. The product is presented as a way to help healthcare organizations identify, prioritize, and act on sourcing opportunities with greater speed and consistency. The logic behind an agentic model is straightforward even without technical detail: if procurement data can be organized more intelligently, teams can move from reactive contract maintenance to proactive opportunity capture. That matters in health systems where procurement departments are expected to do more with fewer staff and where fragmented purchasing behavior can undermine negotiated savings.
The most important clinical parallel is not about medicine itself but about system performance under constraint. Health systems behave like complex biologic networks: when one part leaks efficiency, the whole system absorbs the cost. A weak procurement process does not usually produce a single dramatic failure; it creates repeated small inefficiencies that accumulate across departments and fiscal years. In that sense, better sourcing is less about a one-time fix than about reducing the background friction that drains operational capacity.
Capital expenditures deserve particular attention because they can lock in inefficiency for years if decisions are made without adequate sourcing discipline. A poorly negotiated capital purchase can affect maintenance expenses, service contracts, and future replacement cycles long after the original transaction closes. Indirect spend can create a different kind of problem: because the categories are broad and often decentralized, even well-run organizations can miss opportunities simply because no one has full visibility across the enterprise. The bigger the system, the easier it is for spend to become scattered.
The conversation also reflects a broader shift in healthcare administration. Procurement is no longer just about price. It is about performance, resilience, and the capacity to adapt under financial pressure. Health systems need purchasing models that can find savings without slowing operations or creating unnecessary administrative burden. That is the real challenge buried inside the language of sourcing innovation: not whether organizations can save money in theory, but whether they can do it in a way that is repeatable, scalable, and resilient across diverse facilities and service lines.
The limitations are plain. Procurement tools can surface opportunities, but they do not eliminate the need for disciplined execution, internal alignment, and compliance with negotiated terms. Savings also depend on whether organizations can act on the insights quickly enough to change purchasing behavior. If decision-making stays fragmented, even sophisticated sourcing support will struggle to convert analysis into durable financial improvement. The unanswered operational question is how consistently health systems can turn procurement intelligence into measurable, sustained control over off-contract and unmanaged spend.